Reviewing Jinhua Marine Biological (OTCMKTS:JNMB) and Cresco Labs (OTCMKTS:CRLBF)

Jinhua Marine Biological (OTCMKTS:JNMB) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Profitability

This table compares Jinhua Marine Biological and Cresco Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jinhua Marine Biological	N/A	N/A	N/A
Cresco Labs	-9.15%	-16.10%	-4.83%

Earnings and Valuation

This table compares Jinhua Marine Biological and Cresco Labs”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jinhua Marine Biological	N/A	N/A	N/A	N/A	N/A
Cresco Labs	$770.89 million	0.89	-$175.52 million	($0.20)	-7.00

Jinhua Marine Biological has higher earnings, but lower revenue than Cresco Labs.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Jinhua Marine Biological and Cresco Labs, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jinhua Marine Biological	0	0	0	0	0.00
Cresco Labs	0	3	2	2	2.86

Cresco Labs has a consensus target price of $2.50, suggesting a potential upside of 78.57%. Given Cresco Labs’ stronger consensus rating and higher possible upside, analysts clearly believe Cresco Labs is more favorable than Jinhua Marine Biological.

Institutional & Insider Ownership

0.1% of Cresco Labs shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Cresco Labs beats Jinhua Marine Biological on 6 of the 9 factors compared between the two stocks.

About Jinhua Marine Biological

Jinhua Marine Biological (USA), Inc. develops allopelagic materials, biological medicines, pesticides, environmental protection products, and products for the home. It offers health products, including Xiduoan, which is used for strengthening and adjusting the immune system. The company also introduces advanced wastewater treatment technology, as well as develops environmental protection projects, including industry/urban wastewater treatment. This business was pursued in three areas: the development, manufacture, distribution and sale of ERGOS Systems directly by the Company; consulting services, and the delivery of marketing and other services to ERGOS network providers.

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.